Association between genetic polymorphisms in cytochrome P450 enzymes and survivals in women with breast cancer receiving adjuvant endocrine therapy: a systematic review and meta-analysis

Tamoxifen is commonly prescribed for preventing recurrence in patients with breast cancer. However, the responses of the patients on tamoxifen treatment are variable. Cytochrome P450 genetic variants have been reported to have a significant impact on the clinical outcomes of tamoxifen treatment but...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Carmen Wing Han, Li, Caixia, Xiao, Eleven Jinnan, Li, Minjie, Phiri, Patrick Gladson McLeywick, Yan, Tingting, Chan, Judy Yuet Wa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884795/
https://www.ncbi.nlm.nih.gov/pubmed/34991754
http://dx.doi.org/10.1017/erm.2021.28

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9884795/
https://www.ncbi.nlm.nih.gov/pubmed/34991754
http://dx.doi.org/10.1017/erm.2021.28

Ejemplares similares